Official UK procurement notice
NHS National Pharmaceuticals - Everolimus and terminated agreement products
Authority: The NHS Commissioning Board (operating under the name of NHS England) (NHS & healthcare)
What is being bought3 lots · detail below
Published requirement descriptionPotential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 24 bids on the busiest of 3 lots · 15 suppliers appointed
Lots and requirements (3)Procurement structure
3 lots · no lot values publishedLot #1CM/PHG/21/5632/00 EverolimusAwarded
Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632/00Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Lot #2CM/PHG/21/5632/01 Oral (plus non parenteral) productsAwarded
Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Lot #3CM/PHG/21/5632/02 Hospital Only productsAwarded
Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- “NHS National Pharmaceuticals - Everolimus and terminated agreement…” is a framework: the contest is a place on its panel, not a single contract.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 9 Apr 2021, 15:35 BST
- Last source update
- 28 Sept 2021, 12:36 BST
- Award evaluation window
- 26 Apr 2021 – …
- Authority reference
CM/PHG/21/5632- FTS notice number
2021/S 000-024061- Accelerated
This requirement to call for competition came about due to:i). the availability of competitive supply in circumstances relating to intellectual property rights that could not have been foreseen and/or acted upon by the authority using regular tender timescales, andii). suppliers terminating existing agreements for critical care medicines where there remains an ongoing requirement to procure these medicines.
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02a471Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Performance terms
See KPIs in procurement documents
Publisher note: RESPONDING TO THIS NOTICE;Any supplier may be disqualified who does not respond to the following in the requisite manner:1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.ukCandidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:- agree to the user agreement- populate company details1.2) Once registered, candidates must register interest as follows:- log to the portal- select "Find Opportunities" from the supplier home screen, use the "Sort by:" facility to find this opportunity and select the bold blue title to select- review opportunity details and click "Register Interest"- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at [email protected] or by calling 0800 9956035 for technical assistance when completing responses.2) General supplier information.To manage and assess supplier information the Contracting Authority requests candidates provide theircompany profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:2.1) If not already registered (the previous sid4gov password, login and details will stillbe on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.ukand select "Register" at the top of the page.Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B.Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.D&B data will be supplied automatically by D&B.2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via themessage function on the website.OTHER CONTRACTING AUTHORITIESThe framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.
How it was run
Official noticeTender documents are also served through a separate tool: http://health.atamis.co.uk ↗
- Appointment period ends
- 26 Apr 2021, 13:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 26 Apr 2021, 13:00 BST
Timeline
26 Apr 2021 → 28 Sept 2021 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown26 Apr 2021, 13:00 BST
- Bids opened26 Apr 2021, 13:00 BST
- Notice published28 Sept 2021, 12:36 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete28 Sept 2021, 12:36 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast45 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
All 20 of these contracts carry the same published figure, £1, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
NHS National Pharmaceuticals - Everolimus and terminated agreement products
- Signed
- 8 Jun 2021
- Value
- ceiling above
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · CM/PHG/21/5632/00 Everolimus | 3bids · 3 electronic | 2 | — | — |
| 2 · CM/PHG/21/5632/01 Oral (plus non parenteral) products | 24bids · 24 electronic | 15 | — | — |
| 3 · CM/PHG/21/5632/02 Hospital Only products | 4bids · 4 electronic | 3 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Framework contractors & participating bidders
15 commercial parties on the notice- Accord-UK LtdFramework contractor
- Bowmed Ibisqus LimitedFramework contractor
- Bristol Laboratories LimitedFramework contractor
- Crescent Pharma LtdFramework contractor
- Dr.Reddy's Laboratories (UK) LimitedFramework contractor
- Drugsrus LtdFramework contractor
- Fresenius Kabi LimitedFramework contractor
- Martindale PharmaFramework contractor
- Medreich PLCFramework contractor
- Milpharm Ltd/aurobinbdoFramework contractor
Show 5 more suppliers
- MylanFramework contractor
- Ranbaxy UKFramework contractor
- Selective Supplies Ltd.Framework contractor
- Teva UK LimitedFramework contractor
- Torrent Pharma UK LtdFramework contractor
Official documents & specifications (1)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria